جستجوی استاد راهنمای دانشگاهی

• Clinical Psychology
• Health Psychology
• Substance Use Disorders
• +۹ مورد دیگر

Laura Robinson is a Senior Lecturer at the School of Psychology , University of Wollongong. She holds a Doctor of Philosophy in Psychology and extensive teaching experience in behavioral sciences, statistics, and applied psychology. Education : PhD in Psychology (2017), Postgraduate Diploma in Psychology (2010), Bachelor of Psychology (2009), and Bachelor of Aviation (2004) Her research focuses on vulnerable populations, particularly women and youth, with expertise in substance use disorders, eating disorders, mental health comorbidity, and health equity. She has published extensively on residential treatment outcomes, continuing care interventions, and stigma reduction in mental healthcare. Recent publications highlight longitudinal analyses of psychological distress, weight stigma, and integrated approaches to substance use and physical health. She supervises PhD students on topics like veterans' mental health, methamphetamine use, and suicide prevention. Laura has received funding from internal and external sources, including grants for stimulant use interventions and health literacy studies. She serves on committees like the Australasian Professional Society for Alcohol and Drugs and contributes to peer-reviewed journals as a reviewer.

Ahmad Haririمشاهده پروفایل

استاد

• Psychology
• Neuroscience
• Molecular Genetics
• +۳ مورد دیگر

Professor Ahmad Hariri is a faculty member in the Department of Psychology & Neuroscience at Duke University, part of the Trinity College of Arts & Sciences. He holds affiliations with the Duke-UNC Brain Imaging and Analysis Center, the Duke Institute for Brain Sciences, and the Duke Initiative for Science & Society. His research integrates neuroimaging, pharmacology, and molecular genetics to study biological pathways underlying individual differences in behavior and psychopathology risk. Education: Ph.D. in Psychology from UCLA (2000), M.S. and B.S. in Psychology from the University of Maryland, College Park (1997, 1994). Research interests include understanding how genetic and environmental factors influence brain function and behavior, with a focus on psychopathology, stress, and resilience. His work explores neural correlates of traits like psychopathy, childhood adversity effects on brain structure, and biomarkers of aging. Recent studies highlight links between lead exposure and neurodegeneration, neighborhood disadvantage and dementia risk, and the role of brain connectivity in self-regulation. Key achievements include over 200 publications, including high-impact papers in Nature Aging , Neuron , and Biological Psychiatry . Honors include the APA Distinguished Scientific Award for Early Career Contribution (2009) and being named a Highly Cited Researcher (2014). Grants include leadership roles in the Duke-NCCU Postdoctoral Training Program in Child Psychiatric Conditions and the Duke Psychiatry Physician-Scientist Residency Program. He has contributed to editorial boards of journals like Cortex and Biology of Mood and Anxiety Disorders . Professional activities include mentoring in the Summer Neuroscience Program and serving as a Bass Connections Faculty Team Leader.

• Addictive Disorders
• Genetics
• Substance Use Disorders
• +۳ مورد دیگر

Yaira Zoé Núñez is a Researcher in the Division of Human Genetics at the Yale School of Medicine. Her work focuses on genetic and epidemiological factors underlying substance use disorders, including cannabis, opioid, alcohol, and methamphetamine addictions. She collaborates extensively with the Gelernter Lab and other institutions on large-scale genomic studies. Research Interests: Genetic basis of addictive disorders Multi-ancestry genome-wide association studies (GWAS) Epidemiology of polysubstance use Clinical correlates of substance use disorders Key Collaborations: Works with Prof. Joel Gelernter, Renato Polimanti, and international teams. Recent studies include: Multicenter analysis of gambling disorder in methamphetamine users (2025) Multi-ancestry cannabis use disorder GWAS (2023) Genetic risk loci for opioid use disorder (2022) Labs/Teams: Core member of the Gelernter Lab, contributing to translational research bridging genetics and clinical addiction medicine. Active in collaborative networks analyzing large-scale biomedical data.

Amanda Fallin-Bennettمشاهده پروفایل

دانشیار

• Tobacco Use
• Substance Abuse
• Recovery Frameworks
• +۷ مورد دیگر

Amanda Fallin-Bennett, Ph.D., is an Associate Professor at the University of Kentucky College of Nursing , with affiliations in the Cancer Prevention and Control Research Program and the Markey Cancer Center. Her work focuses on substance use , harm reduction , and health equity , particularly for vulnerable populations. Education: Doctor of Philosophy (2011), University of Kentucky Master of Science in Nursing (2009), University of Kentucky Bachelor of Science in Nursing (2007), University of Kentucky Her research explores polysubstance use , recovery frameworks , and public health policy , with recent articles addressing fentanyl test strip utilization , recovery capital in justice-involved women , and reproductive health access for recovery communities. She emphasizes health equity in tobacco control and social justice in substance use prevention. Scientific Awards: Nursing Grant Scholars (2016) Research Protégé of the Year (2019) Vernon Johnson Recovery Advocate of the Year (2019) Scholar Award (2017) Research Award (2019) She actively leads grants like the UK Harm Reduction Hub and Smoke-Free Policy and Behavioral Health initiatives, collaborating with Vital Strategies and KY Cabinet for Health and Family Services. Her work spans opioid use disorder , tobacco cessation , and policy implementation in rural Southern states.

• Epidemiology of Drug Use
• Opioid Agonist Treatment
• Pharmacoepidemiology
• +۴ مورد دیگر

Dr. Gráinne Cousins is an Associate Professor at the School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland (RCSI). She specializes in epidemiology of drug use, with a focus on opioid agonist treatment, gender disparities in drug-related mortality, and prescription drug misuse. Her work integrates data linkage studies, cohort analyses, and Delphi consensus methods. She holds memberships in the Psychological Society of Ireland and the Society for the Study of Addiction, and serves on the National Drug Strategy Research Sub-Committee since 2022. Dr. Cousins completed her BA in Applied Psychology at University College Cork (1996–1999), MSc in Health Psychology at NUI Galway (2000–2002), and PhD in Population Health Sciences at RCSI (2006–2009). She was a Post-doctoral Research Fellow at the HRB Centre for Primary Care Research (2009–2013) before joining RCSI as a Lecturer in 2013, progressing to Senior Lecturer (2017) and Associate Professor (2023). Her research interests include pharmacoepidemiology, population health, and opioid substitution treatment. She leads HRB-funded projects on drug misuse trends, OAT adaptations during the pandemic, and prescription drug-related harms. Recent publications analyze overdose mortality, pandemic treatment adjustments, and gabapentinoid prescribing patterns. Dr. Cousins supervises 13 completed PhD/MSc students and currently guides 3 Professional Doctorate candidates. She teaches Research Methods, Global Health, and Clinical Research Skills across undergraduate and postgraduate programs. Her grants include HRB awards for OAT continuity during crises and prescription drug misuse analysis (2021–2024).

• Substance Use Disorders
• Alcohol Use Disorders
• Tobacco Use Disorders
• +۵ مورد دیگر

Walter Roberts is an Assistant Professor in the Psychiatry Department at Yale School of Medicine with a secondary appointment in Biomedical Informatics & Data Science. A licensed clinical psychologist specializing in substance use treatment, particularly alcohol and tobacco use disorders, he combines clinical expertise with technological innovation in his research program. Dr. Roberts received his PhD in Clinical Psychology from the University of Kentucky in 2016. His research program employs multiple methodologies to identify the causes and consequences of substance use in humans, with a focus on developing mobile biosensor platforms that can passively detect and predict substance use behaviors. These systems, built using machine learning and informatics techniques, aim to improve assessment and targeted delivery of interventions in clinical and research settings. He also investigates risk factors for hazardous alcohol use using clinical and epidemiological data and maintains an active interest in research ethics related to substance use research. Dr. Roberts' publication record reveals a strong focus on alcohol use disorders, with increasing integration of digital phenotyping and AI technologies in recent years. His work spans from traditional clinical studies to cutting-edge investigations using wearable technology and machine learning. The research shows a clear trajectory toward developing objective, real-time assessment methods for substance use behaviors, with particular attention to sex and gender differences in alcohol-related outcomes. Recent publications demonstrate growing interest in ethical considerations surrounding digital technologies in substance use research. MD2K Training Institute Summer Scholar (2023) Early Career Scientist Award from CHADD (2015) Enoch Gordis Award Finalist from Research Society on Alcoholism (2013) Dr. Roberts serves as a Sub Investigator on multiple clinical trials related to alcohol addiction and mental health, including studies examining the effects of acute stress and inflammation on drinking behavior, combining varenicline and guanfacine for smoking cessation, and investigating whether propranolol attenuates stress-induced drinking. His collaborative network includes frequent co-authors such as Sherry McKee, Terril Luce, MacKenzie Peltier, Yasmin Zakiniaeiz, and Bubu Banini. His research has been featured in YaleNews, highlighting work on using smartwatches to better understand psychiatric illness.

YiYuan Tangمشاهده پروفایل

استاد

• Health Neuroscience
• Science of Behavior Change
• Brain/Mind-Body Interaction
• +۱۳ مورد دیگر

Dr. Yi-Yuan Tang is a Professor at Arizona State University’s College of Health Solutions and Director of the Health Neuroscience Collaboratory . He is also a Presence Fellow at Stanford University’s Center for Advanced Study in the Behavioral Sciences. Top 2% Most Cited Scientist Author of >360 peer-reviewed articles Editorial roles in SCAN, Frontiers in Neuroimaging, PloS One Research Focus: Health neuroscience integrating neuroimaging , physiological monitoring , and interventional methods to study self-control, emotion regulation, and brain-body interactions. Key projects include NIH-funded studies on polysubstance use reduction and effortless attention control . Scientific Achievements: NIH Cutting-Edge Basic Research Award NIH Phased Innovation Award American Congress of Rehabilitation Medicine Award Stanford Presence Fellow Mentoring: Supervised >70 graduate students/postdocs across psychology, neuroscience, health sciences, and data science. Serves on federal grant panels for NIH, DoD, NASA, and NSF.

Zoe Walterمشاهده پروفایل

مدرس ارشد

• Substance Use Disorders
• Mental Health Promotion
• Trauma-Informed Care
• +۳ مورد دیگر

Dr. Zoe Walter is a Senior Lecturer at the School of Psychology, The University of Queensland, with affiliations to multiple research centers including the National Centre for Youth Substance Use Research, Social Identity and Groups Network (SIGN), and the Centre for Health Outcomes, Innovation and Clinical Education (CHOICE). PhD in Psychology (UQ, 2017) Bachelor (Honours) of Psychological Science (UQ, 2011) Her research focuses on substance use disorders, trauma-informed care, social identity theory, and mental health interventions for university students and homeless populations. She has developed innovative programs like Sharper Minds for student mental health and trauma-informed models for residential treatment facilities. Recent work analyzes polysubstance use patterns, pandemic impacts on student mental health, and social network interventions to reduce alcohol consumption. She explores how social identification enhances therapeutic outcomes and informs public health strategies. UQ Knowledge Exchange & Translation Fund (2023) Australian Rotary Health Research Fund (2019-2021) Commonwealth Department of Social Services (2017-2018) Dr. Walter supervises PhD candidates in topics including loneliness in rural cancer survivors, PIED use determinants, and psychosocial recovery after brain injury. She contributes to open data policy critiques and mental health demonstration projects.

• Substance Use Epidemiology
• Psychiatric Epidemiology
• Opioid Policy Analysis
• +۴ مورد دیگر

Silvia S. Martins, MD, PhD, is Professor of Epidemiology at Columbia University Mailman School of Public Health, where she directs the Substance Use Epidemiology Unit and co-directs the NIDA T32 Substance Abuse Epidemiology Training Program. She serves as Vice Dean for Faculty and holds affiliations with Columbia's Global Health Initiative, Injury Science Center, and Population Research Center. Her education includes an MD from UFPR-Brazil (1998) and a PhD from the University of São Paulo (2003). Dr. Martins' research examines substance use epidemiology through interdisciplinary lenses, focusing on: Policy impacts of cannabis/opioid regulations on overdose rates and usage patterns Machine learning applications for analyzing drug policy effectiveness Child/adolescent psychiatric epidemiology and global substance use disparities Urban health interventions and community-based substance abuse prevention Her work spans national contexts including the U.S., Brazil, and Uruguay. Her publications demonstrate strong thematic coherence, with recent work emphasizing: Quantitative analysis of cannabis/opioid policy impacts using longitudinal data Innovative methods (e.g., machine learning, geospatial modeling) in epidemiological research Health equity dimensions of substance policies across racial/ethnic groups Maternal health and polysubstance use during public health crises Awards & Honors: Tow Leadership Scholar (2021-2023) Columbia University Irving Medical Center Mentor of the Year (2021) Calderone Health Equity Award (2021) National Hispanic Science Network Mentoring Award (2021) Dean's Award for Excellence in Mentoring (2017) Joseph Ciarrocchi Award for Youth Gambling Research (2011) As principal investigator on multiple NIH grants since 2006, she leads projects examining: Synergistic effects of opioid/cannabis policies in the U.S. Drug overdose trends in Latin America (Brazil, Colombia, Mexico) Unemployment insurance effects on drug outcomes during COVID-19 She mentors early-career researchers through the NIDA T32 program, with >90 mentee-led publications. She directs the Substance Use Epidemiology Unit and co-leads the PHIOS interdisciplinary group. Additional affiliations include Columbia’s Center for Injury Science and Prevention, Institute of Latin American Studies, and Global Mental Health Program.

Edythe Londonمشاهده پروفایل

استاد

• Neuroimaging
• Addiction Neuroscience
• Neuropharmacology
• +۲ مورد دیگر

Edythe London, Ph.D., is a Distinguished Professor-in-Residence at UCLA with joint appointments in the Departments of Psychiatry and Biobehavioral Sciences and Molecular & Medical Pharmacology. She holds membership in the Brain Research Institute, CTSI Molecular Pharmacology, and Neuroscience GPB Home Area. Her research utilizes neuroimaging to investigate neural circuitry underlying addiction and self-control behaviors. She earned her Ph.D. in Pharmacology from the University of Maryland and completed postdoctoral training at Johns Hopkins School of Medicine. Prior to joining UCLA in 2001, she directed the NIDA Brain Imaging Center and held faculty positions at the University of Maryland and Johns Hopkins. Dr. London's research focuses on neuroimaging of addiction mechanisms, with emphasis on: Neural substrates of methamphetamine and nicotine dependence mGlu5 receptor function in substance use disorders Sex differences in neuropharmacology Structural and functional brain alterations in addiction Neuromodulation therapies for craving reduction Her publications demonstrate consistent focus on addiction neurobiology, particularly through multi-modal neuroimaging (fMRI, PET, MRS) and large-scale consortia work with ENIGMA-Addiction. Significant honors include: Nathan B. Eddy Lifetime Achievement Award (2023) McLean Hospital Women in Science Lectureship (2020) H.W. Magoun Lectureship (2019) AAAS Scientific Freedom & Responsibility Award (2011) She leads translational research through NIH-funded projects on neuropharmacological interventions and maintains extensive collaborations through the ENIGMA-Addiction Working Group.

• Substance Use Disorders
• Opioid Use Disorder
• Methamphetamine Use Disorder
• +۴ مورد دیگر

Larissa J Mooney is a Clinical Professor in the Department of Psychiatry and Biobehavioral Sciences at the University of California, Los Angeles (UCLA) School of Medicine. Her research and clinical work focuses on substance use disorders, with particular expertise in opioid use disorder, methamphetamine use disorder, and cannabis use disorder. She has received multiple NIH grants as a Co-Principal Investigator for studies related to addiction treatment and behavioral interventions. Dr. Mooney's research interests center on developing and evaluating interventions for substance use disorders, with a strong emphasis on medication-assisted treatment, telemedicine applications in rural settings, and understanding the impact of social determinants of health on treatment outcomes. Her work explores how exercise interventions might affect neural function in methamphetamine users, how decision aids can improve medication treatment for opioid use disorder, and how functional outcomes change with reductions in cannabis use. She has made significant contributions to understanding the relationship between co-occurring mental health conditions and substance use disorders, and how these comorbidities affect treatment outcomes. Analysis of Dr. Mooney's recent publications reveals a strong focus on rural healthcare disparities in substance use treatment, telemedicine applications during and after the pandemic, and the impact of social determinants of health on treatment outcomes. Her work increasingly examines how to expand access to medication for opioid use disorder in primary care settings, particularly in underserved rural communities. There's also a clear emphasis on understanding demographic disparities in treatment outcomes and developing tailored interventions for special populations including youth and those with co-occurring disorders. Dr. Mooney has served as Co-Principal Investigator on multiple NIH-funded research projects including: Greater Southern California Node of the Clinical Trials Network (NIH UG1DA049435) Exercise in Methamphetamine Use Disorder: Dopamine Receptor Upregulation and Neural Function (NIH R01DA045162) Patient Decision Aid for Medication-Assisted Treatment for Opioid Use Disorder (NIH R33DA045844 and R21DA045844) Assessing Functional Outcomes Associated with Reductions in Cannabis Use (NIH R33DA042280 and R21DA042280) Her work has been widely disseminated through numerous publications in high-impact journals, and she collaborates extensively with researchers across multiple institutions including USC, UC Davis, and other UC campuses. Dr. Mooney is particularly active in translating research findings into clinical practice, with a focus on improving access to evidence-based treatments for substance use disorders in community settings.

• Substance misuse prevention
• Polysubstance use
• Alcohol epidemiology
• +۷ مورد دیگر

Dr. Gary C.K. Chan is an NHMRC Emerging Leadership Fellow at the National Centre for Youth Substance Use Research within the School of Psychology at the University of Queensland. As a statistical advisor, he provides methodological guidance to academic staff and research higher degree students. His collaborative work spans major international research institutions including the University of Washington, Murdoch Children's Research Institute, University of Melbourne, and University College London, with significant policy impact through consultation with the United Nations Office of Drugs and Crime. Dr. Chan's principal research focuses on substance misuse prevention and advanced statistical methods for longitudinal analysis. His work examines polysubstance use patterns (particularly alcohol, tobacco, and cannabis) among adolescent populations, urban-rural disparities in substance use, and the epidemiology of various substances. He applies sophisticated statistical modeling to understand complex relationships between substance use, mental health, and sociodemographic factors, with particular attention to methodological innovations in addiction research. Dr. Chan's prolific publication record demonstrates a strong focus on contemporary substance use issues, particularly cannabis and vaping trends among youth. His research employs diverse methodologies including longitudinal analysis, systematic reviews, and wastewater-based epidemiology. There's a clear emphasis on policy-relevant research that examines the impact of regulatory changes on substance use patterns, with significant contributions to understanding cannabis use for medicinal purposes and the relationship between social media exposure and substance use behaviors. Scientific Awards: NHMRC Emerging Leadership Fellowship As a statistical advisor at the School of Psychology, Dr. Chan provides methodological support to academic staff and research higher degree students. Since 2016, he has conducted advanced statistical workshops on R programming and multilevel modeling. His research is supported through the NHMRC fellowship and numerous collaborations with major national and international institutes that facilitate large-scale epidemiological studies and policy-relevant analyses. Dr. Chan is affiliated with the National Centre for Youth Substance Use Research at the University of Queensland. His collaborative network spans multiple research teams across continents, enabling comprehensive investigations of substance use patterns and their determinants in diverse populations and settings.

Wendy Kliewerمشاهده پروفایل

استاد

• Substance Use Prevention
• Adolescent Development
• Risk and Resilience
• +۳ مورد دیگر

Wendy Kliewer is a tenured Professor in Virginia Commonwealth University's Department of Psychology (College of Humanities and Sciences), specializing in international health psychology with joint appointments in Clinical, Health, and Social Psychology programs. She coordinates the Humphrey Fellowship Program and leads research on adolescent substance use prevention across low- and middle-income countries. Her educational background includes: Ph.D. in Social Ecology, University of California, Irvine (1989) M.S. in Psychology, Portland State University (1983) B.A. in Psychology, Southern California College (1980) Dr. Kliewer's research centers on substance use prevention and adolescent risk/resilience factors , with emphasis on cultural contexts in Africa and South Asia. She develops capacity-building initiatives for researchers in resource-limited settings and enhances VCU's addiction studies curriculum through community-engaged approaches. Her 2023-2025 publications reveal dominant trends in global health disparities , using systematic/scoping reviews to analyze community violence, child marriage, and substance misuse interventions. Recurring methodological themes include cross-cultural comparisons and mixed-methods designs addressing social determinants of health. Award highlights include: APA Fellow (Division 52, International Psychology) VCU Distinguished Mentoring Award (2017) Presidential Award for Community Multicultural Enrichment (2017) Fulbright Research Fellowship to South Africa (2010-2011) As a dedicated mentor, she guides undergraduate researchers through VCU's URSA program and supervises Humphrey Fellows' research capacity development. Her grant portfolio includes NIH-funded international collaborations and Fulbright grants supporting South African youth studies. Dr. Kliewer co-leads the iCubed initiative and Developmental Psychology Hub, fostering interdisciplinary teams focused on trauma-informed interventions for vulnerable youth across multiple continents.

Abenaa Jonesمشاهده پروفایل

استادیار

• Substance Use Disorders
• Criminal Justice
• Women's Health
• +۸ مورد دیگر

Dr. Abenaa Jones is an Assistant Professor in the Department of Human Development and Family Studies at Pennsylvania State University, where she holds the Ann Atherton Hertzler Early Career Professorship. As director of the Addiction, Sex, and Infectious Diseases (ASID) Lab, her research focuses on the syndemic of substance use disorders, violence, sexual risk behaviors, and HIV/STIs, particularly among marginalized and criminal justice-involved women. B.S., 2012, Public and Community Health, University of Maryland Ph.D., 2016, Epidemiology, University of Florida Her work examines racial disparities in opioid overdose training, naloxone administration, and treatment access, with a focus on gender-specific interventions for criminal justice-involved women. She evaluates structural and behavioral strategies to reduce substance use harms, including medication-assisted treatment (MAT) and trauma-informed care integration. Dr. Jones’ research emphasizes multidisciplinary approaches to addiction, intersecting with social determinants like housing instability and incarceration stigma. She has secured significant funding, including an NIDA K01 Career Development Award and NIH T32 training grant, to develop interventions that address systemic barriers to recovery. Scientific awards include: Ronald E. McNair Scholar’s Program (2009) McKnight Doctoral Fellowship (2012) NIDA Diversity Scholar (2019) Bloomberg American Health Initiative Travel Award (2019) She mentors PhD students in Human Development and Family Studies and collaborates across institutions, including the Consortium to Combat Substance Abuse and the Edna Bennett Pierce Prevention Research Center. Her lab integrates expertise from epidemiology, demography, and clinical practice to address addiction and infectious disease intersections.

• Public Health
• Harm Reduction
• Substance Use and Addiction
• +۱۲ مورد دیگر

Karla Wagner is an Associate Professor in the School of Public Health at the University of Nevada, Reno. She is a behavioral scientist whose research focuses on mitigating health harms among people who use drugs, with continuous funding from the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) since 2008. Her work employs mixed methods and qualitative approaches to study harm reduction interventions, overdose prevention, and substance use patterns, particularly related to methamphetamine and opioids. Education: Ph.D. in Preventive Medicine (Health Behavior Research), University of Southern California Postdoctoral Fellowship, Division of Global Public Health, University of California, San Diego M.A. in Applied Anthropology, Northern Arizona University B.A. in Anthropology and Minor in Biology, University of Colorado, Boulder Her research interests include harm reduction, overdose prevention, substance use disparities, social determinants of health, and the intersection of public health and criminal justice. She has led and co-led multiple federally funded studies, including projects on naloxone distribution, methamphetamine use in the Mountain West, and social networks of overdose responders. Her recent publications reflect a strong trend in qualitative and mixed methods research focused on marginalized populations, with recurring themes of fentanyl contamination, peer recovery support, and structural barriers to health. She frequently collaborates with students and community partners, evidenced by co-authored publications and community-engaged research. Scientific Awards: No awards explicitly mentioned in the text. Dr. Wagner actively mentors students, as indicated by the asterisked student authors on her publications. She has received significant grant funding from NIH/NIDA and CDC, supporting her ongoing research in public health interventions. She teaches graduate courses in mixed methods and applied public health research, contributing to the training of future public health professionals. Her work is often conducted in collaboration with community-based organizations and public health departments, particularly in Nevada and New Mexico, focusing on real-world implementation of harm reduction strategies. She is involved in developing tools such as simulation models for public health officials and evaluating peer-based interventions in emergency departments.